Advanced Bifurcation Systems
1451 Quail St. Ste: 104
Newport Beach
California
92660
United States
Tel: 949-432-4824
Website: http://advancedbifurcation.com/
Email: info@advancedbifurcation.com
About Advanced Bifurcation Systems
Advanced Bifurcation Systems (“ABS”) is a clinical stage medical device company developing an innovative stenting platform for simple treatment of all bifurcation lesions in coronary angioplasties. ABS has developed a novel technology which overcomes the limitations of current approaches while simplifying the procedure. The Company’s groundbreaking system consists of numerous differentiating features, including a unique modular independently movable dual-catheter system for provisional side-branch stenting as well as full bifurcation stenting with a proprietary crimping technology allowing for partial crimping of the main stent.
LEADERSHIP:
Founder and CMO: Mehran J. Khorsandi
Founder and CTO: Henry Bourang
CEO: Charles A. Laverty
CFO:Ken Richards Vice President of Global Business Development: Drew Foster
13 articles about Advanced Bifurcation Systems
-
Advanced Bifurcation Systems Announces First Closing of Series A Financing
12/17/2020
Advanced Bifurcation Systems, Inc., a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, is pleased to announce the first closing of an $11 million Series A equity financing.
-
ADVANCED BIFURCATION SYSTEMS GRANTED FOUR ADDITIONAL PATENTS
9/21/2018
Advanced Bifurcation Systems today announced that the Company has been granted four additional patents, three in the U.S. and one in Europe.
-
ADVANCED BIFURCATION SYSTEMS FILES PRE-SUBMISSION WITH FDA TO DEFINE CLINICAL PATHWAY; OUTLINES REGULATORY AND CLINICAL STRATEGY FOR EUROPE TO OBTAIN CE MARK
9/18/2018
Advanced Bifurcation Systems today announced that the Company has submitted a proposal to the U.S. Federal Drug Administration (“FDA”) for a clinical study leading to an IDE for its bifurcation technology. Concurrently, the Company is defining a regulatory and clinical strategy for Europe to receive a CE mark.
-
Advanced Bifurcation Systems Announces Livermore Global Manufacturing Center
8/21/2018
Medical device manufacturer, Advanced Bifurcation Systems® announced today that it has selected a facility in Livermore California for its first manufacturing facility.
-
Advanced Bifurcation Selected to Join MaRs Venture Services
6/27/2018
Advanced Bifurcation Systems (“ABS” or the “Company”), today announced that ABS, through its wholly-owned Canadian subsidiary, Advanced Bifurcation Systems Canada, Inc. (“ABS Canada”) has been selected to join MaRS Venture Services.
-
Advanced Bifurcation Systems Announces Plans for Asian Expansion
3/14/2018
Advanced Bifurcation Systems (ABS), a medical stenting technology company, today announced plans to increase their footprint in Asian markets through partnerships in the region.
-
Advanced Bifurcation Systems Appoints Industry Veteran Thomas O’Neill to Board of Directors
1/25/2018
Mr. O'Neill is an industry veteran who brings more than 30 years of Board and executive-level experience in the financial markets and medical devices to ABS.
-
Charles Laverty Announces Major Expansion Plans at Advanced Bifurcation Systems
1/15/2018
The company has developed a novel technology to overcome limitations in the current approach to bifurcation lesions in coronary angioplasties.
-
Advanced Bifurcation Systems Poised for Breakthrough Success With Strong Patent Protection
1/5/2018
A breakthrough stenting technology is being developed by ABS and with 34 patents in place to protect their intellectual property it would be hard to bet against them.
-
Advanced Bifurcation Systems Announces Scott King Joins as Chief of Compliance Ahead of FDA Application
1/5/2018
ABS Scott King has joined the leadership team as VP of Regulatory Affairs.
-
ABS Sets Their Sights on $20M in New Funding Led by New CFO
1/5/2018
The new goal was announced in conjunction with the appointment of new CFO Ken Richards, who brings with him a strong background in both debt and equity financing.
-
ABS Release: Major Heart Treatment to Eliminate Thousands of Open Heart Surgeries
1/5/2018
Advanced Bifurcation Systems is developing a new procedure that could potentially eliminate the need for open-heart surgery in thousands of patients every year.
-
Advanced Bifurcation Systems Announces Plan For Human Clinical Trials In New Brunswick, Canada
10/3/2017